Overview   Delegates   Presenting Companies   Sponsors   Videos   Photos   Selection Committee   Agenda & Hotel Information   Press Room   Testimonials   Registration



ETT would like to thank its sponsors for their generous support. If you are interested in sponsoring this Tech Tour, please contact us at info@techtour.com or Tel: +41 22 544 6062.

Global Partners

Egon Zehnder International was founded in 1964 in Zurich and today the firm specializes in Board Effectiveness Reviews, Leadership Strategy Services and Executive Search at the Management and Board levels. The Firm has a distinctive vision and structure aimed at achieving two basic goals - placing clients' interests first and to lead its profession in creating value for its clients through the assessment and recruitment of top-level management resources. The Firm has a structure which is unique in its profession. The Firm's 385 consultants, operating from 63 wholly owned offices in 37 countries, are organized around a single-profit center partnership. This is designed to eliminate competitive barriers between offices. It allows the Firm to operate seamlessly when engagements call for multi-office, cross collaboration and knowledge sharing. Large or small, local or global, clients benefit from this structure by having access to the Firm's most relevant resources and relationships wherever they may reside.

Founded in 1988 by Aletta and Peter Stas and driven by passion, Frederique Constant has grown into one of the larger Swiss watch manufacturers. In 2011, production reaches over 120'000 watches, sold in over 2'700 points of sale in 100+ countries around the globe. Frederique Constant positions itself in the Accessible Luxury segment, with most of its watches selling at CHF 1'000-5'000 retail. The company is expected to continue its annual 25% growth, doubling in size every three years. Over the years, we have earned a reputation as a leading maker of Swiss luxury watches despite the relative youth of our brand. The quality of our watches and the detail involved in crafting each watch is only part of our success story; the rest was driven by watch aficionados and lovers of our brand who saw that we had something different and unique to offer. It is by appealing to this same group of people that we hope to make a difference in the lives of many by soliciting for their support to extend the same affection they have for the brand, towards charities and causes we are associated with.

Gold Sponsors

The mission of the Department for Economic Affairs of the State of Vaud is to put in place the framework conditions required to promote economic growth. Its objectives are designed to highlight the know-how of companies and to make the canton an attractive and competitive environment.

The vitality of economy in the Canton of Vaud is particularly remarkable in state-of-the-art industries with high added value such as life sciences, information technology, micro- and nanotechnology, environmental and agri-food technologies. Strong political support and many concrete state support and incentives serve to reinforce growth in these sectors.

BioBay is located in Dushu Lake Higher Education Town of Suzhou Industrial Park (SIP). Suzhou Industrial Park (SIP), the largest cooperation program between China and Singapore, is committed to building a globally competitive high-tech industrial park. BioBay is a key driver for innovation and a key focus of growth at SIP, and is a leader in the development of bio and nanotechnology throughout China. More than 260 high-tech innovative companies covering drug discover, medical device , diagnostic, CRO/CMO and nano material have been located in BioBay, as well as Cold Spring Harbor Asia Conference Center, and 5000 scientists and professionals have come to join this dynamic innovative community.

Bronze Sponsors

D-TARGET is the leading expert in medical device clinical investigations and strategic regulatory services to manufacturers from all over the world. Since 1997, our global team of highly experienced professionals have helped companies both large and small to navigate the complex maze of medical device clinical research to bring their products to market. From 10-patient feasibility studies to 10,000-patient post-marketing trials, D-TARGET offers you complete and dedicated support throughout the product life cycle:

The Biosensors International group of companies develop, manufacture and market innovative medical devices for interventional cardiology and critical care procedures. Our aim is to improve patients' lives through pioneering medical technology that pushes forward the boundaries of innovation.

Gimv is a European investment company with over three decades experience in private equity and venture capital. The company is listed on NYSE Euronext Brussels and currently manages around 1.8 billion EUR (including third party funds) of investments in 85 portfolio companies, which jointly realise a turnover of more than EUR 6 billion and employ over 28,000 professionals. As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv

NeoMed Management is an international investment firm, exclusively focussing on the healthcare and life science industry. Founded in 1996, NeoMed has established four funds, with total committed capital exceeding $200 million. NeoMed invests in young companies with outstanding growth prospects. Portfolio companies typically develop innovative products addressing inadequately served medical needs in the following industry sectors: pharmaceuticals, biotechnology drugs, diagnostics, medical devices and instruments. NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has backed more than 30 companies in the USA and Europe, including Scandinavia, Switzerland, Germany and the UK. From offices in Norway, Switzerland and the US East Coast, NeoMed

The Entrepreneurs Fund is the venture capital member of the COFRA Group, a global, family-controlled group of businesses. The Entrepreneurs Fund has

Local Support Partners

ChampionScott Partners is a leading global executive search firm focused exclusively on the technology industry and related sectors. Our firm delivers the personalized focus of a technology boutique combined with the research resources and global reach of a large international firm. We recruit CEOs, their direct reports, and Board Directors for companies ranging from early-stage VC-backed to the Global 500 in the key technology centers of the US, China, Japan and Europe through our offices around the world.

PACTT is the joint technology transfer office of the University of Lausanne and the University Hospital of Lausanne. PACTT enables the local scientific talent to reach the market for the public good: protection of intellectual property rights, negotiation of contracts, identification of potential industrial partners, contribution to development of business plans and supporting creation of local start-up companies. The office was founded in February 2000, following the signature of an agreement between the University of Lausanne (UNIL) and the University Hospital of Lausanne (CHUV). The operating costs are shared between the two Institutions.

Salus Partners is a Swiss based investment and advisory firm active in the financial and healthcare industries. We have a special expertise in proven health technologies and seek to generate exceptional returns while bringing good outcomes to society. Salus Partners delivers independent wealth optimization advise and applies its expertise on potential Direct and Co-investment opportunities.

The Lausanne University Hospital (CHUV) is one of the 5 Swiss hospitals. Through its collaboration with the Faculty of biology and medicine of the University of Lausanne, the CHUV plays a role of European scale advanced in the areas of health care, medical research and training.

Media & Communication Partners

Elsevier Business Intelligence, a global leader in the field of healthcare industry information, provides business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, e-learning, databases and reports, Elsevier Business Intelligence places medical device and biopharma professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis.

Founded in 1993, Cukierman & Co. Investment House Ltd is the leading European focused investment house, headquartered in Israel. We provide a full array of investment banking services including Corporate Finance, Private Equity, Family office and Strategic Consulting to Israeli and European companies. Since its establishment, Cukierman & Co. has been engaged in transactions valued at

Clinica Medtech Intelligence is the leading provider of news, analysis & competitor intelligence for the global medical devices and diagnostics industries. Clinica is read by all the major companies in the medtech industry and is renowned for providing timely news, must-read analysis and value-added intelligence. We provide the medtech industry with new product approvals, global R&D, key policy & regulatory developments, mergers & acquisitions, investment & partnering, essential market data & market trend analysis. A subscription to Clinica Medtech Intelligence now also includes access to over 30 SCRIP Insights medtech and IVD reports.

Venture Valuation specializes in independent assessments and valuations of companies in high-growth markets, such as biotechnology, life sciences and medical technology. Clients include investors like corporate, VCs, family offices as well as the management of companies. Valuations have also been done in the food and food additive sector. Furthermore, the company runs the global Biotech Database (www.biotechgate.com) as a subscription service as well as a white label solution for clients like BIOTECanada, BioCom San Diego, Maryland, HoustonBIO, OneNucleus, Swiss Exchange SIX, Swiss Biotech Association, SwedenBIO, Medicon Valley and many more.

OneMedPlace is a communications platform for healthcare and life sciences companies to connect with investors, strategic partners and customers.Through our news services, radio interviews, video production, and research, OneMedPlace specializes in delivering information to investors covering nanocap, microcap and private emerging growth companies in the hottest areas of life sciences. Established in 2008, OneMedForum is the conference component of OneMedPlace, showcasing the best ideas and innovations from around the world. The 3-day conference features over 1,000 attendees, consisting of private investors, venture capitalists, angel networks and private equity, as well as strategic partners, licensees, advisors and research analysts. The 6th Annual OneMedForum takes place January 7th-9th in San Francisco. Visit www.OneMedForum.com to learn more about programming!

The World Medtech Forum is a high-caliber platform for the international medtech sector

Industry Support

The European Private Equity and Venture Capital Association (EVCA) is a member-based, non-profit trade association that was established in 1983 and is based in Brussels. EVCA represents, promotes and protects the interests of the European private equity and venture capital industry. Specifically, EVCA

EBAN - The European Trade Association for Business Angels, Seed Funds, and other Early Stage Market Players is a pan-European organization gathering over 100 member organizations from 27 countries, including business angels networks and federations of networks, early stage venture capital funds (investing less than 3 million euros per transaction, and interested in cross-border collaboration with angels). EBAN represents circa 250 angel groups in Europe via direct or indirect membership, reaching out to 20.000 angels and receiving circa 40.000 business plans a year. It was established in 1999 with the collaboration of the European Commission by a group of pioneer angel networks in Europe. EBAN

Powered by e-unlimited.com
Registration & Profiling Platform v1.3.6297.20376
Copyright ©1998-2019 Europe Unlimited - All rights reserved